Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
(4R)-7,8-dichloro-1',9-dimethyl-1-oxo-1,2,4,9-tetrahydrospiro[beta-carboline-3,4'-piperidine]-4-carbonitrile is a synthetic small molecule belonging to the beta-carboline class of organic compounds. It features a spiro-fused piperidine and beta-carboline core with dichloro and dimethyl substitutions. The compound has been studied as an experimental agent and is known in structural biology as ligand 7CP. It has been used in crystallographic studies for its ability to bind kinases such as death-associated protein kinase 3 (DAPK3), suggesting potential activity as a kinase inhibitor. However, there are no approved indications or clinical uses reported for this compound at present[1][6][9].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on (4R)-7,8-dichloro-1',9-dimethyl-1-oxo-1,2,4,9-tetrahydrospiro[beta-carboline-3,4'-piperidine]-4-carbonitrile.